Washington Trust’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Washington Trust’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34	Closed	-$7K	–	1098
2021 Q1	$7K	Hold	34	–	–	﹤0.01%	802
2020 Q4	$4K	Hold	34	–	–	﹤0.01%	827
2020 Q3	$3K	Hold	34	–	–	﹤0.01%	849
2020 Q2	$4K	Sell	34 -15	-31%	-$1.7K	﹤0.01%	735
2020 Q1	$4K	Buy	+49	New	+$5.19K	﹤0.01%	789

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Washington Trust's GWPH Position: Q2 2021 in Review

Washington Trust sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 34 shares — an estimated $7K sold.

Washington Trust first reported a position in GWPH in Q1 2020 and held it in 5 quarters. The position peaked at $7K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Washington Trust reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Washington Trust sold 34 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7K.
Washington Trust first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 5 quarters.
Washington Trust's GW Pharmaceuticals Plc American Depositary Shares position peaked at $7K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Washington Trust's 13F filing for Q2 2021, filed 5 Aug 2021.